Key result
New 7-variable risk score predicts no-reflow in STEMI PCI with an AUC of ~0.81.
Why the study?
Can a new scoring system accurately predict no-reflow and 1-year major adverse cardiovascular events in STEMI patients undergoing PCI?
Observational (n=1,147)
Yes
Can a new scoring system accurately predict no-reflow and 1-year major adverse cardiovascular events in STEMI patients undergoing PCI?
A novel 7-variable risk score can effectively predict the development of no-reflow in STEMI patients undergoing PCI, potentially guiding pre-procedural management.
Answers are grounded in this paper and cite their sources.
May support pre-PCI risk stratification in STEMI; hypothesis-generating pending external validation and outcome trials.
BACKGROUND: No-reflow is associated with a poor prognosis in STEMI patients. There are many factors and mechanisms that contribute to the development of no-reflow, including age, reperfusion time, a high thrombus burden, Killip class, long stent use, ejection fraction ≤40, and a high Syntax score. In this study, we aimed to evaluate the parameters associated with no-reflow prediction by creating a new scoring system. METHODS: The study included 515 consecutive STEMI patients who underwent PCI; 632 STEMI patients who had undergone PCI in another center were included in the external validation of the scoring system. The correlations between 1-year major adverse cardiac events and low/high risk score were assessed. RESULTS: In this study, seven independent variables were used to build a risk score for predicting no-reflow. The predictors of no-reflow are age, EF ≤40, SS ≥22, stent length ≥20, thrombus grade ≥4, Killip class ≥3, and pain-balloon time ≥4 h. In the derivation group, the optimal threshold score for predicting no-reflow was >10, with a 75% sensitivity and 77.7% specificity (Area under the curve (AUC) = 0.809, 95%CI: 0.772-0.842, P < 0.001). In the validation group, AUC was 0.793 (95%CI: 0.760-0.824, P < 0.001). CONCLUSION: This new score, which can be calculated in STEMI patients before PCI and used to predict no-reflow in STEMI patients, may help physicians to estimate the development of no-reflow in the pre-PCI period.
No takes yet. Share an insight, caveat, or question.
Bayramoğlu et al. (2017) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=1,147). New risk scoring system for predicting no-reflow was evaluated on Prediction of no-reflow (AUC 0.809, 95% CI 0.772-0.842, p=< 0.001). A new 7-variable risk score successfully predicted no-reflow in STEMI patients undergoing PCI, achieving an AUC of 0.809 in the derivation cohort.
Synapse has enriched 10 related papers. Consider them for comparative context: